Clinical Trials Browser

Phase 1/2 × Breast Neoplasms, Male × Antibodies, Monoclonal × Clear all

NCT03112590 2023-04-19

Phase I-II Study of Interferon-gamma in Patients With HER-2 Positive Breast Cancer

Phase 1/2 Completed

51 enrolled 13 charts

Breast Neoplasms, Breast Neoplasms, Male